148 related articles for article (PubMed ID: 35459888)
1. Germline variant in Ctcf links mental retardation to Wilms tumor predisposition.
Gargallo P; Oltra S; Tasso M; Balaguer J; Yáñez Y; Dolz S; Calabria I; Martínez F; Segura V; Juan-Ribelles A; Llavador M; Castel V; Cañete A; Font de Mora J
Eur J Hum Genet; 2022 Nov; 30(11):1288-1291. PubMed ID: 35459888
[TBL] [Abstract][Full Text] [Related]
2. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
3. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
Coppes MJ; Liefers GJ; Paul P; Yeger H; Williams BR
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1416-9. PubMed ID: 8381965
[TBL] [Abstract][Full Text] [Related]
4. WT1 mutations may be a cause of severe renal failure due to nephroblastomatosis in Wilms' tumor patients.
Santín S; Fraga G; Ruíz P; Pardo N; Torrent M; Martí T; Ballarín J; Ars E; Torra R
Clin Nephrol; 2011 Sep; 76(3):244-8. PubMed ID: 21888862
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity.
Filippova GN; Qi CF; Ulmer JE; Moore JM; Ward MD; Hu YJ; Loukinov DI; Pugacheva EM; Klenova EM; Grundy PE; Feinberg AP; Cleton-Jansen AM; Moerland EW; Cornelisse CJ; Suzuki H; Komiya A; Lindblom A; Dorion-Bonnet F; Neiman PE; Morse HC; Collins SJ; Lobanenkov VV
Cancer Res; 2002 Jan; 62(1):48-52. PubMed ID: 11782357
[TBL] [Abstract][Full Text] [Related]
6. Familial Wilms' tumor associated with a WT1 zinc finger mutation.
Kaplinsky C; Ghahremani M; Frishberg Y; Rechavi G; Pelletier J
Genomics; 1996 Dec; 38(3):451-3. PubMed ID: 8975729
[No Abstract] [Full Text] [Related]
7. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
8. TRIM28 haploinsufficiency predisposes to Wilms tumor.
Diets IJ; Hoyer J; Ekici AB; Popp B; Hoogerbrugge N; van Reijmersdal SV; Bhaskaran R; Hadjihannas M; Vasileiou G; Thiel CT; Seven D; Uebe S; Ilencikova D; Waanders E; Mavinkurve-Groothuis AMC; Roeleveld N; de Krijger RR; Wegert J; Graf N; Vokuhl C; Agaimy A; Gessler M; Reis A; Kuiper RP; Jongmans MCJ; Metzler M
Int J Cancer; 2019 Aug; 145(4):941-951. PubMed ID: 30694527
[TBL] [Abstract][Full Text] [Related]
9. Molecular insight into multiple Wilms tumors arising in germline WT1-mutated/11p13-deleted patients.
Perotti D
Pediatr Blood Cancer; 2018 Nov; 65(11):e27360. PubMed ID: 30015390
[No Abstract] [Full Text] [Related]
10. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
11. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
12. The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.
Pritchard-Jones K; Renshaw J; King-Underwood L
Hum Mol Genet; 1994 Sep; 3(9):1633-7. PubMed ID: 7833922
[TBL] [Abstract][Full Text] [Related]
13. A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.
Hancock AL; Brown KW; Moorwood K; Moon H; Holmgren C; Mardikar SH; Dallosso AR; Klenova E; Loukinov D; Ohlsson R; Lobanenkov VV; Malik K
Hum Mol Genet; 2007 Feb; 16(3):343-54. PubMed ID: 17210670
[TBL] [Abstract][Full Text] [Related]
14. The molecular genetics of Wilms tumor.
Coppes MJ; Williams BR
Cancer Invest; 1994; 12(1):57-65. PubMed ID: 8281465
[No Abstract] [Full Text] [Related]
15. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
[TBL] [Abstract][Full Text] [Related]
16. Constitutional and somatic deletions of two different regions of maternal chromosome 11 in Wilms tumor.
Jeanpierre C; Antignac C; Beroud C; Lavedan C; Henry I; Saunders G; Williams B; Glaser T; Junien C
Genomics; 1990 Jul; 7(3):434-8. PubMed ID: 1973142
[TBL] [Abstract][Full Text] [Related]
17. Confirmation of Xp22.11 Duplication as a Germline Susceptibility Alteration in a Wilms Tumor Arising in Horseshoe Kidney.
Zhou HF; Amarillo IE; Snyder S; Granadillo JL; O'Conor CJ; Dillon P; Wilson D; Huang FS; Dehner LP; He M
Fetal Pediatr Pathol; 2022 Aug; 41(4):682-688. PubMed ID: 33960268
[No Abstract] [Full Text] [Related]
18. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
Haber DA; Buckler AJ; Glaser T; Call KM; Pelletier J; Sohn RL; Douglass EC; Housman DE
Cell; 1990 Jun; 61(7):1257-69. PubMed ID: 2163761
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic abnormalities in mesoblastic nephroma: a link to Wilms' tumour?
Roberts P; Lockwood LR; Lewis IJ; Bailey CC; Batcup G; Williams J
Med Pediatr Oncol; 1993; 21(6):416-20. PubMed ID: 8390601
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.
Morris JF; Madden SL; Tournay OE; Cook DM; Sukhatme VP; Rauscher FJ
Oncogene; 1991 Dec; 6(12):2339-48. PubMed ID: 1662794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]